Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT05969860

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Led by Mayo Clinic · Updated on 2026-04-20

220

Participants Needed

2

Research Sites

175 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Currently most drug-related cancer care is conducted in infusion centers or specialty hospitals, where patients spend many hours a day isolated from family, friends, and familiar surroundings. This separation adds to the physical, emotional, social, and financial burden for patients and their families. The logistics and costs of navigating cancer treatments have become a principal contributor to patients' reduced quality of life. It is therefore important to reduce the burden of cancer in the lives of patients and their caregivers, and a vital aspect of this involves moving beyond traditional hospital and clinic-based care and evaluate innovative care delivery models with virtual capabilities. Providing cancer treatment at-home, versus in the clinic, may help reduce psychological and financial distress and increase treatment compliance, especially for marginalized patients and communities.

CONDITIONS

Official Title

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female patients with confirmed cancer diagnosis or imaging diagnosis of hepatocellular carcinoma
  • Receiving standard-of-care treatment regimen approved or recommended by national guidelines
  • Receiving one of the specified eligible cancer types and treatment regimens
  • Adequate tolerability of current cancer treatment without drug-related infusion reactions
  • Plan to continue current treatment for at least 24 weeks after randomization
  • Living within the service area of the home health and paramedic network
  • Residence has wifi or suitable wireless network connection
  • Age 18 years or older at registration
  • Signed informed consent
  • Able and willing to follow the study protocol
  • Eastern Cooperative Oncology Group Performance Status of 0, 1, or 2
  • Ability to complete study questionnaires alone or with help
  • Confirmation of tolerability and no infusion reactions prior to randomization
Not Eligible

You will not qualify if you...

  • Receiving other investigational cancer treatments outside the study protocol
  • Needing 24/7 help with daily living activities
  • Currently hospitalized as an inpatient (except Advanced Care at Home program)
  • Severe or uncontrolled medical illnesses that interfere with study safety or assessments
  • Active infections or unstable heart conditions including recent heart attack
  • Wound healing problems
  • Psychiatric or social issues limiting study compliance

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Mayo Clinic in Florida

Jacksonville, Florida, United States, 32224-9980

Actively Recruiting

2

Altru Cancer Center

Grand Forks, North Dakota, United States, 58201

Actively Recruiting

Loading map...

Research Team

C

Clinical Trials Referral Office

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here